Towards global control of liver cancer?

Seminars in Cancer Biology

Volumn 8, Issue 4, 1998, Pages 299-306

  Stuver, Sherri O ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Aflatoxins; Hepatitis B virus; Hepatitis C virus; Liver cancer; Prevention

Indexed keywords

AFLATOXIN; HEPATITIS B VACCINE; ORAL CONTRACEPTIVE AGENT;

ALCOHOL CONSUMPTION; DEVELOPING COUNTRY; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CANCER; LIVER CELL CARCINOMA; NONHUMAN; REVIEW; SMOKING;

EID: 0031740458     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.1998.0079     Document Type: Article

References (115)

1. 1. Parkin DM, Pisani P, Ferlay J (1993) Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 54:594-606
2. 2. Pisani P, Parkin DM, Muñoz N, Ferlay J (1997) Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev 6:387-400
3. 3. Pisani P, Parkin DM, Ferlay J (1993) Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer 55:891-903
4. 4. Bosch FX (1997) Global epidemiology of hepatocellular carcinoma, in Liver Cancer (Okuda K, Tabor E, eds) pp. 13-28. Churchill Livingstone, New York
5. 5. Muñoz N, Linsell A (1982) Epidemiology of primary liver cancer, in Epidemiology of Cancer of the Digestive Tract (Correa P, Haenszel W, eds) pp. 161-195. Martinus Nijhoff, The Hague
6. 6. Tanaka H, Hiyama T, Okubo Y, Kitada A, Fujimoto I (1994) Primary liver cancer incidence-rates related to hepatitis-C virus infection: a correlational study in Osaka, Japan. Cancer Causes Control 5:61-65
7. 7. Stuver SO, Trichopoulos D (1994) Liver cancer, in Trends in Cancer Incidence and Mortality, vol. 19/20 (Doll R, Fraumeni J, Muir C, eds) pp. 99-124. Imperial Cancer Research Fund, London. Cancer Surveys
8. 8. Cady B (1983) Natural history of primary and secondary tumors of the liver. Seminars Oncol 10:127-134
9. 9. International Agency for Research on Cancer (1994) Hepatitis Viruses. IARC, IARC Monogr Eval Carcinog Risk Humans, vol. 59, Lyon
10. 10. Ross RK, Yuan J-M, Yu MC et al (1992) Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 339:943-946
11. 11. Adami H-O, Hsing AW, McLaughlin JK et al (1992) Alcoholism and liver cirrhosis in the etiology of primary liver cancer. Int J Cancer 51:898-902
12. 12. Austin H (1991) The role of tobacco use and alcohol consumption in the etiology of hepatocellular carcinoma, in Etiology, Pathology, and Treatment of Hepatocellular Carcinoma in North America (Tabor E, Di Bisceglie AM, Purcell RH, eds) pp. 13:57-75. Adv Applied Biotech Series, Houston
13. 13. Thomas DB (1991) Exogenous steroid hormones and hepatocellular carcinoma, in Etiology, Pathology, and Treatment of Hepatocellular Carcinoma in North America (Tabor E, Di Bisceglie AM, Purcell RH, eds) pp. 13:77-89. Adv Applied Biotech Series, Houston
14. 14. Parkin DM, Srivatanakul P, Khlat M et al (1991) Liver cancer in Thailand. I. A case-control study of cholangiocarcinoma. Int J Cancer 48:323-328
15. 15. International Agency for Research on Cancer (1987) Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs 1-42. IARC, IARC Monogr Eval Carcinog Risk Humans, Suppl 7, Lyon
16. 16. Stuver SO, Boschi-Pinto C, Trichopoulos D (1997) Infection with hepatitis B and C viruses, social class and cancer, in Social Inequalities and Cancer (Kogevinas M, Pearce N, Susser M, Boffetta P, eds) pp. 319-324. IARC. IARC Scientific Publications No 38, Lyon
17. 17. Okuda K, Fujimoto I, Hanai A, Urano Y (1987) Changing incidence of hepatocellular carcinoma in Japan. Cancer Res 47:4967-4972
18. 18. Muñoz N, Bosch FX (1987) Epidemiology of hepatocellular carcinoma, in Neoplasms of the Liver (Okuda K, Ishaki KG, eds) pp. 3-19. Springer, Tokyo
19. 19. Yu M-W, Chen C-J (1993) Elevated serum testosterone levels and risk of hepatocellular carcinoma. Cancer Res 53:790-794
20. 20. Szmuness W, Stevens CE, Ikram H et al (1978) Prevalence of Hepatitis B virus infection and hepatocellular carcinoma in Chinese-Americans. J Infect Dis 137:822-829
21. 21. Tabor E (1988) Etiology, diagnosis, and treatment of viral hepatitis in children. Adv Pediatr Infect Dis 3:19-46
22. 22. Thomas HC (1990) The hepatitis B virus and the host response. J Hepatol 11:583-589
23. 23. Maupas P, Melnick JL (1981) Hepatitis B infection and primary liver cancer. Prog Med Virol 27:1-5
24. 24. Beasley RP (1988) Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 61:1942-1956
25. 25. Chang M-H, Chen D-S, Hsu H-C, Hsu H-Y, Lee C-Y (1989) Maternal transmission of hepatitis B virus in childhood hepatocellular carcinoma. 64:2377-2380
26. 26. Muñoz N, Lingao A, Lao J et al (1989) Patterns of familial transmission of HBV and the risk of developing liver cancer: a case-control study in the Philippines. Int J Cancer 44: 981-984
27. 27. Hsieh C-c, Tzonou A, Zavitsanos X, Kaklamani E, Lan S-J, Trichopoulos D (1992) Age at first establishment of chronic hepatitis B infection and hepatocellular carcinoma risk: a birth order study. Am J Epidemiol 136:1115-1121
28. 28. Popper H (1988) Relation between hepatocellular carcinoma and persistent hepatitis B infection. Appl Pathol 6:64-72
29. 29. Tabor E (1991) Strongly supported features of the association between hepatitis B virus and hepatocellular carcinoma, in Etiology, Pathology, and Treatment of Hepatocellular Carcinoma in North America (Tabor E, Di Bisceglie AM, Purcell RH, eds) pp. 13:107-117. Adv Applied Biotech Series, Houston
30. 30. Okuda K, Nakashima T, Sakamoto K et al (1982) Hepatocellular carcinoma arising in noncirrhotic and highly cirrhotic livers: a comparative study of histopathology and frequency of hepatitis B markers. Cancer 49:450-455
31. 31. Trichopoulos D, Day NE, Kaklamani E et al (1987) Hepatitis B, tobacco smoking and ethanol consumption in the etiology of hepatocellular carcinoma. Int J Cancer 39:45-49
32. 32. Tabor E (1997) The role of tumor suppressor genes in the development of hepatocellular carcinoma, in Liver Cancer (Okuda K, Tabor E, eds) pp. 89-95. Churchill Livingstone, New York
33. 33. Tabor E (1992) Hepatitis C virus and hepatocellular carcinoma. AIDS Res Human Retrovirus 8:793-796
34. 34. Alter HJ (1995) To C or not to C: these are the questions. Blood 85:1681-1685
35. 35. van der Poel CL (1994) Hepatitis C virus, in Epidemiology, Transmission and Prevention. Hepatitis C Virus (Ressink HW, ed) pp. 137-163. Karger, Amsterdam
36. 36. Kiyosawa K, Tanaka E, Sodeyama T et al (1994) Transmission of hepatitis C in an isolated area in Japan: community-acquired infection. Gastroenterol 106:1596-1602
37. 37. Nakashima K, Ikematsu H, Hayashi J, Kishihara Y, Mitsutake A, Kashiwagi S (1995) Intrafamilial transmission of hepatitis C virus among the population of an endemic area of Japan. J Am Med Assoc 274:1459-1461
38. 38. Tanaka K, Stuver SO, Ikematsu H et al (1997) Heterosexual transmission of hepatitis C virus among married couples in southwestern Japan. Int J Cancer 72:50-55
39. 39. Alter MJ, Hadler SC, Judson EN et al (1990) Risk factors for non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. J Am Med Assoc 264:2231-2235
40. 40. Alter MJ (1996) Epidemiology of hepatitis C. Eur J Gastroenterol Hepatol 8:319-323
41. 41. Hoofnagle JH (1997) Hepatitis C: the clinical spectrum of disease. Hepatology 26(Suppl 1):15S-20S
42. 42. Alter MJ, Margolis HS, Krawczynski K et al (1992) The natural history of community-acquired hepatitis C in the United States. N Engl J Med 37:1899-1905
43. 43. Alter HJ, Conry-Catilena C, Melpolder J et al (1997) Hepatitis C virus in asymptomatic blood donors. Hepatology 26(Suppl 1):29S-33S
44. 44. Kiyosawa K, Sodeyama T, Tanaka E et al (1990) Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 12:671-675
45. 45. Takahashi M, Yamada G, Miyamoto R, Doi T, Endo H, Tsuji T (1993) Natural course of chronic hepatitis C. Am J Gastroenterol 88:240-243
46. 46. Nishioka K, Watanabe J, Furuta S et al (1991) A high prevalence of antibody to the hepatitis C virus with hepatocellular carcinoma in Japan. Cancer 67:429-433
47. 47. Verbaan H, Widell A, Lindgren S, Lindmark B, Nordenfelt E, Eriksson S (1992) Hepatitis C in chronic liver disease: an epidemiologic study based on 566 consecutive patients undergoing liver biopsy during a 10-year period. J Intern Med 232:33-42
48. 48. Yu MC, Tong MJ, Govindarajan S, Henderson BE (1991) Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles county, California. J Natl Cancer Inst 83:1820-1826
49. 49. Kaklamani E, Trichopoulos D, Tzonou A et al (1991) Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. J Am Med Assoc 265:1974-1976
50. 50. Stroffolini T, Chiaramonte C, Tiribelli C et al (1992) Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinoma: relative risk and population attributable risk from a case-control study. J Hepatol 16:360-363
51. 51. Simonetti RF, Gamma C, Fiorello F et al (1992) Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study. Ann Intern Med 116:97-102
52. 52. Tsai J-F, Jeng J-E, Ho M-S, Chang W-Y, Lin Z-Y, Tsai J-H (1994) Hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Chinese: a case-control study. Int J Cancer 56:619-621
53. 53. Sun C-A, Farzadegan H, You S-L et al (1996) Mutual confounding and interactive effects between hepatitis-C-and hepatitis-B-viral infections in hepatocellular carcinogenesis: a population-based case-control study in Taiwan. Cancer Epidemiol Biomarkers Prev 5:173-178
54. 54. Donato F, Boffetta P, Puoti M (1998) A meta-analysis of epidemiologic studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 75:347-354
55. 55. Tanaka K, Hirohata T, Koga S et al (1991) Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res 51:2842-2847
56. 56. Chang C-C, Yu M-W, Lu C-F, Yang C-S, Chen C-J (1994) A nested case-control study on association between hepatitis-C-virus antibodies and primarily liver cancer in a cohort of 9775 men in Taiwan. J Med Virol 43:276-280
57. 57. Tabor E, Kobayashi K (1992) Hepatitis C virus, a causative infectious agent of non-A, non-B hepatitis: prevalence and structure - summary of a conference on hepatitis C virus as a cause of hepatocellular carcinoma. J Natl Cancer Inst 84:86-90
58. 58. Shiratori Y, Shiina S, Imamura M et al (1995) Characteristic difference of hepatocellular carcinoma between hepatitis B-and C-viral infection in Japan. Hepatology 22:1027-1033
59. 59. Geissler M, Gesien A, Wands JR (1997) Molecular mechanisms of hepatocarcinogenesis, in Liver Cancer (Okuda K, Tabor E, eds) pp. 59-88. Churchill Livingstone, New York.
60. 60. Tanaka E, Kiyosawa K, Matsushita T et al (1995) Epidemiology of genotypes of hepatitis C virus in Japanese patients with type C chronic liver diseases. J Gastroenterol Hepatol 10:538-545
61. 61. Tanaka K, Ikematsu H, Hirohata T, Kashiwagi S (1996) Hepatitis C virus infection and risk of hepatocellular carcinoma among Japanese: possible role of type 1b (II) infection. J Natl Cancer Inst 88:742-746
62. 62. Okuda K. Hepatitis C virus and hepatocellular carcinoma (1997), in Liver Cancer (Okuda K, Tabor E, eds) pp. 39-50. Churchill Livingstone, New York
63. 63. International Agency for Research on Cancer (1993) Some Naturally Occurring Substances: Food Items and Constituents, Heterocyclic Aromatic Amines and Mycotoxins. IARC, IARC Monogr Eval Carcinog Risk Humans, vol 56, Lyon
64. 64. Bosch FX, Muñoz N (1989) Epidemiology of hepatocellular carcinoma, in: Liver Cell Carcinoma (Bannasch P, Keppler D, Weber G, eds) pp. 3-14. Falk Symposium No 51. Kluwer Academic, Dordrecht
65. 65. Montesano R, Hainaut P, Wild CP (1997) Hepatocellular carcinoma: from gene to public health. J Natl Cancer Inst 89:1844-1851
66. 66. Yeh F-S, Yu MC, Mo C-C, Luo S, Tong MJ, Henderson BE (1989) Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res 49:2506-2509
67. 67. Alpert ME, Hutt MSR, Wogan GN, Davidson CS (1971) Association between aflatoxin content of food and hepatoma frequency in Uganda. Cancer 28:353-360
68. 68. Bulatao-Jayme J, Almero EM, Castro MCA, Jardeleza MTR, Salamat LA (1982) A case-control dietary study of primary liver cancer risk from aflatoxin exposure. Int J Epidemiol 11:112-119
69. 69. Lam KC, Yu MC, Leung JWC, Henderson BE (1982) Hepatitis B virus and cigarette smoking: risk factors for hepatocellular carcinoma in Hong Kong. Cancer Res 42:5246-5248
70. 70. Srivatanakul P, Parkin DM, Khlat M et al (1991) Liver cancer in Thailand. II.Case-control study of hepatocellular carcinoma. Int J Cancer 48:329-332
71. 71. Qian G-S, Ross RK, Yu MC et al (1994) A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev 3:3-10
72. 72. Wogan GN (1997) Aflatoxin exposure as a risk factor in the etiology of hepatocellular carcinoma, in Liver Cancer (Okuda K, Tabor E, eds) pp. 51-58. Churchill Livingstone, New York
73. 73. La Vecchia C, Negri E, Decarli A, D'Aranzo B, Franceschi S (1988) Risk factors for hepatocellular carcinoma in Northern Italy. Int J Cancer 42:872-876
74. 74. Vall Mayans M, Calvet X, Bruguera M et al (1990) Risk factors for hepatocellular carcinoma in Catalonia, Spain. Int J Cancer 46:378-381
75. 75. Yu MC, Tong MJ, Coursaget P, Ross RK, Govindarajan S, Henderson BE (1990) Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst 82:1038-1041
76. 76. Tsukuma H, Hiyama T, Oshima A et al (1990) A case-control study of hepatocellular carcinoma in Osaka, Japan. Int J Cancer 45:231-236
77. 77. Mohamed AE, Kew MC, Groeneveld T (1992) Alcohol consumption as a risk factor for hepatocellular carcinoma in urban southern African blacks. Int J Cancer 51:537-541
78. 78. Tanaka K, Hirohata T, Takeshita S et al (1992) Hepatitis B virus, cigarette smoking and alcohol consumption in the development of hepatocellular carcinoma: a case-control study in Fukuoka, Japan. Int J Cancer 51:509-514
79. 79. Fukuda K, Shibata A, Hirohata I, Tanikawa K, Yamaguchi G, Ishii M (1993) A hospital-based case-control study on hepatocellular carcinoma in Fukuoka and Saga prefectures, Northern Kyushu, Japan. Jpn J Cancer Res 84:708-714
80. 80. Tanaka K, Hirohata T, Fukuda K, Shibata S, Tsukuma H, Hiyama T (1995) Risk factors for hepatocellular carcinoma among Japanese women. Cancer Causes Control 6:91-98
81. 81. Kew MC, Popper H (1984) Relationship between hepatocellular carcinoma and cirrhosis. Semin Liver Dis 4:136-146
82. 82. Mendenhall CL, Seeff L, Diehl AM et al (1991) Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: their prevalence and clinical relevance. Hepatology 14:581-589
83. 83. Nalpas B, Driss F, Pol S et al (1991) Association between HCV and HBV infection in hepatocellular carcinoma and alcoholic liver disease. J Hepatol 12:70-74
84. 84. Yamauchi M, Nakahara M, Maezawa Y et al (1993) Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C. Am J Gastroenterol 88:39-43
85. 85. Hsing AW, McLaughlin JK, Hrubec Z, Blot WJ, Fraumeni JF, Jr (1990) Cigarette smoking and liver cancer among US veterans. Cancer Causes Control 1:217-221
86. 86. Trichopoulos D, MacMahon B, Sparros L, Merikas G (1980) Smoking and hepatitis B-negative primary hepatocellular carcinoma. J Natl Cancer Inst 65:111-114
87. 87. Trichopoulos D (1992) Etiology of primary liver cancer and the role of steroidal hormones. Cancer Causes Control 3:3-5
88. 88. Hsing AW, Hoover RN, McLaughlin JK et al (1992) Oral contraceptives and primary liver cancer among young women. Cancer Causes Control 2:43-48
89. 89. Tavani A, Negri E, Parazzini F, Franceschi S, La Vecchia C (1993) Female hormone utilisation and risk of hepatocellular carcinoma. Br J Cancer 67:635-637
90. 90. WHO Collaborative Study of Neoplasia and Steroid Contraceptives (1989) Combined oral contraceptives and liver cancer. Int J Cancer 43:254-259
91. 91. World Cancer Research Fund (1997) Food, Nutrition and the Prevention of Cancer: a Global Perspective. American Institute for Cancer Research, Washington, DC
92. 92. La Vecchia C, Negri E, D'Avanzo B, Boyle P, Franceschi S (1990) Medical history and primary liver cancer. Cancer Res 50:6274-6277
93. 93. Goodman MT, Moriwaki H, Vaeth M, Akiba S, Hayabuchi H, Mabuchi K (1995) Prospective cohort study of risk factors for primary liver cancer in Hiroshima and Nagasaki, Japan. Epidemiology 6:36-41
94. 94. Adami H-O, Chow W-H, Nyrén O et al (1996) Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst 88:1472-1477
95. 95. Deugnier Y, Turlin B (1997) Other causes of hepatocellular carcinoma, in Liver Cancer (Okuda K, Tabor E, eds) pp. 97-110. Churchill Livingstone, New York
96. 96. Blumberg BS (1997) The current state of the prevention of HBV infection, the carrier state and hepatocellular carcinoma. Res Virol 148:91-94
97. 97. Anand BS, Hollinger FB (1997) Prevention of hepatocellular carcinoma with vaccines, in Liver Cancer (Okuda K, Tabor E, eds) pp. 415-424. Churchill Livingstone, New York
98. 98. Whittle WC, Inskip H, Hall AJ, Mendy M, Downes R, Hoare S (1991) Vaccination against hepatitis B and protection against chronic viral carriage in The Gambia. Lancet 337:747-750
99. 99. Maupas P, Chiron J-P, Barin F et al (1981) Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children. Controlled trial in an endemic area (Senegal). Lancet i:289-292
100. 100. Sun ZT, Zhu Y, Stjernsward J et al (1991) Design and compliance of HBV vaccination trial on newborns to prevent hepatocellular carcinoma and 5-year results of its pilot study. Cancer Detect Prev 15:313-318
101. 101. Chen H-L, Chang M-W, Ni Y-H et al (1996) Seroepidemiology of hepatitis B virus infection in children. Ten years of mass vaccination in Taiwan. J Am Med Assoc 276:906-908
102. 102. Heyward WL, Bender TR, McMahon BJ et al (1985) The control of hepatitis B virus infection with vaccine in Yupik Eskimos. Demonstration of safely, immunogenicity, and efficacy under field conditions. Am J Epidemiol 121:914-923
103. 103. Chang M-H, Chen C-J, Lai M-S et al (1997) Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 336:1855-1859
104. 104. Zuckerman AJ (1997) Prevention of primary liver cancer by immunization (editorial). N Engl J Med 336:1906-1907
105. 105. Kane MA, Ghendon Y, Lambert P-H (1991) Hepatitis B in 1990 - where are we and where are we going? The WHO programme for control of viral hepatitis, in Viral Hepatitis and Liver Disease (Hollinger FB, Lemon SM, Margolis H, eds) pp. 706-708. Williams and Wilkins, Baltimore
106. 106. Prince AM (1994) Challenges for development of hepatitis C virus vaccines. FEMS Microbiol Rev 14:273-277
107. 107. Wang JT, Wang TH, Lin JT et al (1995) Effect of hepatitis C antibody screening in blood donors on post-transfusion hepatitis in Taiwan. J Gastroenterol Hepatol 10:454-458
108. 108. Japanese Red Cross Non A, Non B-Hepatitis Research Group (1991) Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of post-transfusion hepatitis. Lancet 338:1040-1041
109. 109. Tobler LH, Busch MP (1997) History of posttransfusion hepatitis. Clin Chem 43:1487-1493
110. 110. Sung J-L (1997) Prevention of hepatitis B and C virus infection for prevention of cirrhosis and hepatocellular carcinoma. J Gastroenterol Hepatol 12(Suppl):S370-376
111. 111. Main J, Thomas HC (1997) Hepatocellular carcinoma: prevention with antiviral drugs, in Liver Cancer (Okuda K, Tabor E, eds) pp. 425-433. Churchill Livingstone, New York
112. 112. Nishiguchi S, Kuroki T, Nakatani S et al (1995) Randomised trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 346:1051-1055
113. 113. Mazzella G, Accogli E, Sottili S et al (1996) Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis. J Hepatol 24:141-147
114. 114. Jacobson LP, Zhang BC, Zhu YR et al (1997) Oltipraz chemoprevention trial in Qidong, People's Republic of China: study design and clinical outcomes. Cancer Epidemiol Biomarkers Prev 6:257-265
115. 115. Kensler TW, He X, Otieno M et al (1998) Oltipraz chemoprevention trial in Qidong, People's Republic of China: modulation of serum aflatoxin albumin adduct biomarkers. Cancer Epidemiol Biomarkers Prev 7:127-134